Bridgewater Bancshares (NASDAQ: BWB) insider details option exercise, share sale
Rhea-AI Filing Summary
Bridgewater Bancshares’ president and CFO reported changes in his ownership of the company’s common stock.
On 12/10/2025, he exercised 6,000 stock options at $7.47 per share and acquired the same number of shares, and also sold 5,211 shares at a weighted average price of $18.049.
After these transactions, he beneficially owns 105,349 shares directly and 1,000 shares indirectly through a spouse’s IRA, and continues to hold multiple stock option awards.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Bridgewater Bancshares (BWB) disclose in this Form 4?
The filing shows that the company’s president and CFO reported an insider stock transaction involving Bridgewater Bancshares common stock, including an option exercise and a share sale on 12/10/2025.
How many Bridgewater Bancshares (BWB) shares did the president and CFO acquire through option exercise?
He exercised 6,000 stock options at an exercise price of $7.47 per share, acquiring 6,000 shares of Bridgewater Bancshares common stock.
How many BWB shares were sold on 12/10/2025 and at what price?
He sold 5,211 shares of Bridgewater Bancshares common stock at a weighted average price of $18.049 per share, with individual trades priced between $18.035 and $18.049.
How many Bridgewater Bancshares (BWB) shares does the officer own after this transaction?
Following the reported transactions, he beneficially owns 105,349 shares of Bridgewater Bancshares common stock directly and 1,000 shares indirectly through a spouse’s IRA.
What stock options does the Bridgewater Bancshares (BWB) officer continue to hold?
He continues to hold several option awards, including an option to buy 6,000 shares at $7.47 expiring on 09/30/2027, an option to buy 23,000 shares at $12.92 expiring on 12/06/2029, and two option grants at an exercise price of $17.5 per share expiring on 02/01/2032.
What do the footnotes in the Bridgewater Bancshares (BWB) Form 4 explain about these options?
The footnotes state that the options were granted under the company’s 2012 and 2017 Combined Incentive and Non-Statutory Stock Option Plans and vest in increments over four or five years based on the original grant dates of 10/1/2017, 12/6/2019, and 2/1/2022.